Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?

To: Rio Jangada who wrote (284)	8/5/1998 1:20:00 AM
From: Dr. Voodoo	Read Replies (1) \| Respond to of 399

It is likely that ARQL has the ability and means to adapt their technology and their business to meet the needs of the pharmaceutical business, which happens to be financially better off now then ever and is much less vulnerable to a stock market collapse than other industries. Do you really believe that this biotech beating is near over? I keep hearing it's not going to get much worse, but we're back at Early Jan levels. Not to mention today's action. Do you think if we get into a collapse like last October that the biotech sector isn't going with it? Would be interested in hearing your opinions. P.S. I wasn't really fishin' with Eric Gordon.